89results about "Digestive electrodes" patented technology

The present invention relates to a device for the prevention and / or treatment of fecal and / or urinary incontinence. The device may fit into a vagina. The device may include a pressure sensor and electrodes. The device may include a lateral projection on the device and / or a skin of the device. In response to intra-abdominal pressure the device may apply electrostimulation with the electrodes, for example to a vaginal mucosa.

The invention relates to the technical field of medical instruments, in particular to a constipation adjuvant therapy appliance and a using method thereof.The constipation adjuvant therapy appliance comprises an insertion tube, a vibration sleeve is arranged at the inner end of the insertion tube, and a vibration motor is arranged in the vibration sleeve; the outer end of the insertion pipe is connected with a medium pipeline used for inputting or outputting a medium into or out of a pipe cavity of the insertion pipe. A plurality of protruding blocks are arranged on the pipe wall of the outer side of the insertion pipe. Through mechanical pressure generated by expansion of the insertion tube and the adjusting cavity of the insertion tube and local stimulation of the outer side protruding block on the rectum wall, low-frequency vibration of the vibration motor in the vibration sleeve is combined, a rectum wall mechanical receptor and a nerve conduction path are cooperatively activated in a multi-mode mode, defecation reflex is triggered, and therefore targeted intervention on defecation reflex disorder of a constipation patient is achieved. The defect that a traditional therapy does not touch a neural mechanism is overcome, and a comprehensive solution from physiological reflex activation to mechanical power enhancement is provided for constipation treatment.

1. A surgical kit for performing surgery for the treatment of reflux disease, the surgical kit comprising the following components: An implantable motion restriction device configured to impede movement of the lower esophageal sphincter relative to the thoracic diaphragm, the device having at least a portion positioned between the angle of His and the thoracic diaphragm; a lubricant including an antimicrobial agent for use in combination with the implantable motion restriction device; and at least one absorbable suture.

The invention discloses a throat electrical stimulation device and method, and the device comprises a nasal feeding tube, one end of which is an insertion end inserted into the stomach of a patient and is used for conveying a nutrient solution; the transparent hose sleeves the nasal feeding tube in a sliding manner; an electrode assembly including a first electrode and a second electrode; the first electrode and the second electrode are sequentially and fixedly arranged outside the transparent hose in a sleeving manner in the direction far away from the insertion end; the first electrode and the second electrode form an electric signal loop through a wire and are used for outputting electrical stimulation pulses to the muscles of the throat of a patient and / or collecting electromyographic signals. The position marking ring is slidably arranged outside the transparent hose in a sleeving mode and located on the side, away from the insertion end, of the second electrode, the distance between the position marking ring and the second electrode is a first set length, and the distance between the second electrode and the insertion end is a second set length. The device can be used for patients with different heights and different physiological anatomical structures, and is high in universality.

An example method includes delivering one or more electrical stimulation signals to a patient, sensing a composite stimulation-evoked signal comprising a composite of signals generated by one or more signal sources in response to the one or more electrical stimulation signals, and controlling delivery of electrical stimulation therapy to the patient based on the composite stimulation-evoked signal.

Esophageal intubation assemblies, esophageal cardiac stimulation and gastric decompression assemblies, and methods for using and making the same are provided.

Systems and methods for implementation of a disposable miniaturized implant for treatment of PostOperative Ileums (POI), a miniaturized implant for treating chronic GI dysmotility (e.g., dysphagia, gastroesophageal reflux disease (GERD), nausea, functional dyspepsia, blockage of transit, and gastroparesis, inflammatory bowel disease) and obesity, by providing electrical stimulation to the part of bowel going through surgery to expedite the healing process while recording the smooth muscle activities simultaneously, or providing stimulation on a treatment location of the GI tract or the branch of the vagus nerve. Systems and methods are also provided for non-invasive, transcutaneous stimulation of anatomy within the abdomen of the patient.

Provided are devices and methods for preventing an episode of incontinence in an individual in need thereof. The devices comprise a sensor and a stimulator electrode that can be implanted into the body of the individual. Once the device is implanted in the individual, the sensor of the device senses a parameter that is associated with a response from the individual that is intended to prevent an episode of incontinence. Then, the device provides an electrical stimulation using the electrode that, together with the response, helps to prevent the episode of incontinence.

The method for determining and treating a patient's diseased tissue induces an energy signal generation from the diseased tissue. An energy sensor structure obtains an energy signal from the patient's tissue. The obtained energy signal is compared in a processor circuit with a known energy signal of the same tissue under normal function of the tissue. If the comparing step determines that the obtained energy signal is different from the known energy signal, the tissue is identified as diseased tissue. The diseased tissue is localized in the patient via the energy signal. A physical disability caused by the localized diseased tissue is diagnosed by an AI module. The physical disability is then treated.

A process of treatment of internal organ oedema is using an electric current delivering electrode system comprising electrodes to be positioned at two places on the outer surface of the internal organ and / or in a liquid carrying vessel of the internal organ and delivering electric current to induce electro-osmosis between the electrodes. An electrode assembly system for this treatment by electro-osmosis includes, in addition to the two electrodes, a control unit adapted to control the current flow between the two electrodes.

Systems and methods for treating bladder and / or bowel dysfunction of a patient includes implanting a lead carrying one or more stimulation elements to apply stimulation energy to one or more target sites. In some examples, the lead can be implanted using one or more of a guidewire, a tear-away sheath, an open surgical approach, a laparoscopic procedure, or endoluminally.

To provide an apparatus for treating a patient suffering from a disorder related to the passageway of the patient's intestines, such as constipation or incontinence.SOLUTION: An apparatus for treatment includes a pump to be implanted in a patient, where the pump is operable on at least one selected portion of the intestines to pump intestinal contents through the passageway of the intestines. The pump includes a constriction device adapted to alternately constrict the selected portion to at least substantially reduce the volume of the passageway of the intestines along the selected portion and release the selected portion to increase the volume of the passageway of the intestines along the selected portion, so that the intestinal contents are displaced through the passageway of the intestines.SELECTED DRAWING: Figure 2A

A system is provided herein for stimulating an anatomical element of a patient. For example, a device may be configured to generate a current, and an electrode device coupled to the device may be configured to apply the current to the anatomical element. Additionally, the system may include a user interface in communication with the implantable pulse generator, the electrode device, or both. In some examples, the user interface may include a first element that is configured to display information associated with the patient. Additionally, the user interface may include a second element that is configured to receive inputs for programming parameters of the current. The user interface may also include a third element that is configured to display diagnostic information associated with applying the current to the anatomical element.

The systems and methods described herein generally relate to adjusting a neurostimulation (NS) therapy based on drug pharmacokinetics of a patient. The systems and methods deliver an NS therapy to a portion of electrodes of a lead positioned proximate to neural tissue of interest, which is associated with a target region. The NS therapy is defined by stimulation parameters. The systems and methods determine a trigger event indicative of a drug being administered to a patient. The drug is configured to affect at least one of the neural tissue of interest or the target region. The systems and methods adjust one or more of the stimulation parameters based on the PS profile.

A system includes at least one electrode configured for transcutaneous stimulation of a pudendal nerve or surrounding perianal tissue or both. The at least one electrode is coupled to a substrate that includes a rectal portion and a buttocks support portion. The rectal portion includes a fecal blocking element. A control module is coupled to the at least one electrode, and includes a microprocessor for controlling operational parameters of the system.

To provide apparatuses and methods for stimulating L cells of the small intestine to produce incretins and other peptides for treatment of various diseases and conditions including diabetes and obesity.SOLUTION: Embodiments of the invention provide apparatuses and methods for stimulating L cells in the intestinal tract to produce incretins for treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for treatment of diabetes by electrically stimulating L cells for secretion of incretins, so as to stimulate or otherwise modulate production of insulin. Particular embodiments provide a swallowable capsule for stimulating L cells in the intestinal tract as the capsule moves through the tract.SELECTED DRAWING: Figure 4

A method for a genital tissue treatment comprises providing a device including a central control unit, an energy generator and an internal applicator, wherein the internal applicator is detachable and includes at least one ring-shaped circular energy delivery element encircling or around the internal applicator, with the at least one circular energy delivery element, inserting the internal applicator into vagina and into or onto the genital tissue, transferring radiofrequency energy into the genital tissue, heating the genital tissue and, wherein the applicator includes at least one temperature sensor in communication with the central control unit or the energy generator and providing a feedback during treatment, wherein the feedback includes changing output of at least one energy delivery element.

To provide apparatuses and methods for stimulating L-cells of the small intestine to produce incretins and other peptides for the treatment of various diseases and conditions including diabetes and obesity.SOLUTION: Embodiments of the invention provide apparatuses and methods for stimulating L-cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide methods and apparatuses for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract.SELECTED DRAWING: None

An automatically adjustable implantable system for managing urinary incontinence, the implantable system comprising a sling having an elongate body member with a proximal portion, a distal portion and an intermediate portion, wherein the intermediate portion is configured to be positioned underneath urethra of a patient; and a shape memory polymer member at least one of coupled with and integrated with the elongate body member, wherein the shape memory polymer member is configured to deform from an initial state to a second state in response to a signal received from a processing circuit, wherein the deformation in the shape memory polymer member allows for adjustments in a tensioning force provided to the elongate body member upon occurrence of a stress event.

An apparatus (100) for treating reflux disease of a human patient. The apparatus comprising an implantable movement restriction device (110) having a shape and size allowing it to be arranged to rest against a fundus wall portion (14) of the patient's stomach (10), such that the movement restriction device is implanted at a position between the thoracic diaphragm (30) of the patient and a portion of the fundus wall, and such that movement of the lower esophageal sphincter (26) of the patient's stomach towards the thoracic diaphragm is restricted to hinder the lower esophageal sphincter from sliding through the opening (32) in the thoracic diaphragm into the patient's thorax. A first electrode arrangement configured to engage and electrically stimulate the lower esophageal sphincter (26) for causing contraction of the lower esophageal sphincter, and a suppression electrode arrangement (150') configured to deliver an electrical suppression signal to the vagus nerve.

A surgical kit for performing a surgical procedure for treating reflux disease, the surgical kit comprising: an implantable movement limiting device (110, 111a, 111b) configured to prevent movement of a subesophageal sphincter relative to a diaphragm, at least partially interposed between the His angle and the diaphragm; a lubricant comprising at least one antibacterial substance for use with an implantable motion limiting device; and at least one absorbable suture (153).

A stimulator device for use in controlling waste storage for a patient. The stimulator device having a set of at least one electrode placed in proximity to a relevant portion of a pudendal nerve. The stimulator device having a pulse generator connected to the set of at least one electrode to provide stimulation input for use by the electrode to stimulate the pudendal nerve. The pulse generator adapted to provide a first type of stimulation to cause waste to be stored within the patient and to provide a second type of stimulation different from the first type of stimulation. The second type of stimulation allows waste to be voided from the patient by blocking nerve impulses that would produce sphincter dyssynergia. An input device to allow an end user to select to apply the first type of stimulation or the second type of stimulation. Variations are also disclosed.

An apparatus (100) for treating reflux disease in a human patient, the apparatus comprising an implantable movement restriction device (110) shaped and sized for placement against a fundus wall portion (14) of the patient's stomach (10), the movement restriction device being positioned for implantation between the patient's pleural diaphragm (30) and a portion of the gastric fundus wall, and configured to restrict movement of the patient's lower esophageal sphincter (26) of the stomach toward the thoracic diaphragm to prevent the lower esophageal sphincter from slipping through an opening (32) in the thoracic diaphragm and into the patient's thoracic cavity. A first electrode arrangement is configured to contact and electrically stimulate the lower esophageal sphincter (26) to cause contraction thereof, and an inhibitory electrode arrangement (150') is configured to transmit an electrical inhibitory signal to the vagus nerve.

Systems, devices, and methods for treating a medical condition of a patient are described. The system for treating a medical condition of a patient includes: a catheter for insertion into the intestine, the catheter having an elongate shaft with a distal portion; and a functional assembly positioned on the elongate shaft distal portion and including at least one treatment element. The at least one treatment element treats target tissue located in the small intestine of the patient by delivering electrical energy to the target tissue. The delivery of the electrical energy electroporates cells of the target tissue.

The present disclosure relates to a device for applying electrical stimulation to biological tissues. Specifically, the present disclosure is related to a device for applying anodal / cathodal biphasic electrical stimulation to beta cells of the pancreas. Through application of biphasic stimulation to beta cells of the pancreas, insulin secretion can be increased in an effort to overcome deficiencies associated with diabetic patients.

A surgical kit for performing a surgical procedure for treating reflux disease, the surgical kit comprising: an implantable movement restriction device (110, 111a, 111b) configured to be hindering movement of the lower esophageal sphincter relative to the thoracic diaphragm, placed at least partly between the angle of His and the diaphragm, a lubricant including at least a bacteriostatic substance for use with the implantable movement restriction device, and at least one resorbable suture (153).

The invention discloses a pelvic floor trigger point multi-mode diagnosis and treatment system based on a flexible electrode, and relates to the technical field of pelvic floor rehabilitation medical instruments. The flexible intervention type electrode device is used for conducting palpation and electromyographic signal collection at the same time, and pelvic floor muscle trigger points are accurately recognized and visualized through a built-in intelligent algorithm. After diagnosis, the system can selectively apply radio frequency thermal therapy and electrical stimulation through the same electrode according to an identification result and perform multi-mode collaborative therapy by combining with manipulation massage, and the radio frequency therapy adopts a frequency self-adaptive algorithm to realize accurate energy effects on different tissue levels; after the treatment is finished, the system can perform myoelectricity evaluation again to form a diagnosis and treatment closed loop.

Medical testing devices and methods of diagnosing are disclosed. One device may include, a catheter; an inflatable balloon located in a distal portion of the catheter, wherein the inflatable balloon is at least partially insertable into a body cavity; one or more pressure sensors located inside the inflatable balloon; an inflating unit in fluid connection with the inflatable balloon; and a control unit attached to the catheter and configured to receive pressure measurements from the one or more pressure sensors; and to control the inflating unit to control the pressure inside the inflatable balloon based on the received measurements.

The application discloses an anorectal muscle electric stimulation training instrument, which comprises an electric stimulation training instrument main body, wherein the electric stimulation training instrument main body comprises a handle body and a stimulation training rod; the stimulation training rod is arranged at the front end of the handle body; two electrode sheets are arranged at the two sides of the end of the stimulation training rod; an arc-shaped ball end is further arranged at the end of the stimulation training rod; and the electrode sheets are electrically connected with an electric stimulation transmitter host. The anorectal muscle electric stimulation training instrument comprises the electric stimulation training instrument main body, and the electric stimulation training instrument main body comprises the handle body and the stimulation training rod. The electric stimulation training instrument main body is used for replacing the fingers of medical staff to perform rectal stimulation training, so that the fatigue of the medical staff is reduced, the infection of bacteria is reduced, and the stimulation efficiency is improved; different stimulation modes can be used according to different patients, the comfort of the patients is improved, and the patients are facilitated to complete defecation.